# Celebrex With Preoperative Chemoradiation - Rectal Cancer

> **NCT00188565** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 39 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00188565
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 39 (ESTIMATED)
- **Last updated:** 2010-08-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188565, "Celebrex With Preoperative Chemoradiation - Rectal Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00188565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*